SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011249
Filing Date
2017-11-09
Accepted
2017-11-09 08:36:11
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 AERI 9.30.201710-Q aerie93017.htm 10-Q 755015
2 AERI 9.30.2017 EX 31.1 aeri9302017ex311.htm EX-31.1 16407
3 AERI 9.30.2017 EX 31.2 aeri9302017ex312.htm EX-31.2 16510
4 AERI 9.30.2017 EX 32.1 aeri9302017ex321.htm EX-32.1 10036
5 AERI 9.30.2017 EX 32.2 aeri9302017ex322.htm EX-32.2 9984
  Complete submission text file 0001628280-17-011249.txt   4246536

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20170930.xml EX-101.INS 860313
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20170930.xsd EX-101.SCH 36044
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20170930_cal.xml EX-101.CAL 50860
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20170930_def.xml EX-101.DEF 139855
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20170930_lab.xml EX-101.LAB 471991
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20170930_pre.xml EX-101.PRE 258689
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 171188398
SIC: 2836 Biological Products, (No Diagnostic Substances)